
NanoTalks by Curapath is your gateway to the future of healthcare nanotechnology. In each episode, we explore the latest trends in lipid and polymer nanoparticles a groundbreaking field transforming how next-generation therapies and vaccines are developed. Discover how these tiny, multifunctional structures can enhance treatment effectiveness, minimize side effects, and open the door to innovations that once seemed out of reach. Join us as we delve into cutting-edge research, clinical insights, and the major advances shaping modern medicine
Hot topics
NanoTalks
- Miguel Ángel Esteve
- 29/01/2026
Antibacterial polymers for medical devices
Explore how antibacterial polymers are shaping safer medical device design by reducing bacterial adhesion and delaying biofilm formation at the material level.
This article examines the role of cationic polymers, including poly-L-lysine and related amino acid–based polymers, as scalable, surface-active solutions for infection prevention, highlighting their relevance for medical devices, quality-controlled manufacturing, and real-world clinical translation.
Keep exploring Curapath Blog , there is more NanoTalks yet to explore
Recent Articles
- Miguel Ángel Esteve
- January 29, 2026
Medical device–associated infections remain a major challenge across healthcare, especially for catheters, orthopedic...
- Miguel Ángel Esteve
- December 18, 2025
Polymer–drug conjugates (PDCs) represents a unique strategy in modern drug delivery: instead of encapsulating a drug...
- Miguel Ángel Esteve
- November 13, 2025
Lipid–polymer hybrid nanoparticles (LPHNs) are emerging as one of the most promising platforms in nanomedicine....
- Miguel Ángel Esteve
- October 15, 2025
Transfection, the process of introducing nucleic acids into cells, is a cornerstone of modern biotechnology, enabling...
- Miguel Ángel Esteve
- September 11, 2025
Functionalized polymers are revolutionizing pharmaceutical science by bridging chemistry and biology in ways that...
- Miguel Ángel Esteve
- July 30, 2025
Replacing PEG in lipid nanoparticles (LNPs) marks a critical evolution in the development of safer and more effective...
- Miguel Ángel Esteve
- July 2, 2025
Over the past 20 years, polymer-based drug delivery systems have evolved from experimental platforms to clinically...
- Miguel Ángel Esteve
- June 9, 2025
In vivo CAR-T therapy using lipid nanoparticles (LNPs) represents a transformative advancement in immunotherapy,...
- Miguel Ángel Esteve
- May 19, 2025
Messenger RNA (mRNA) technology surged into the global spotlight during the COVID-19 pandemic, showcasing its power to...
- Miguel Ángel Esteve
- April 29, 2025
Early-stage research frequently takes center stage in the fields of biopharmaceuticals and the development of advanced...
Keep updated
Sign Up for NanoTalks
Subscribe to NanoTalks, the magazine of Curapath. Stay up to date on the latest developments, trends and news in the world of non-viral vectors, plus discover the latest advances in nanobiotechnology.
